TherapeuticsMD, Inc. (TXMD) Free cash flow 2016–2022
TherapeuticsMD, Inc. (TXMD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$9.3MFY2022 · since FY2016: -$69.3M → $9.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $9.3M | +106.5% |
| FY2021 | -$142.9M | +11.7% |
| FY2020 | -$161.9M | +2.4% |
| FY2019 | -$165.9M | -55.3% |
| FY2018 | -$106.9M | -39.6% |
| FY2017 | -$76.6M | -10.5% |
| FY2016 | -$69.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TXMD financial trends
TXMD RevenueTXMD Net incomeTXMD Net marginTXMD Gross profitTXMD Gross marginTXMD Operating incomeTXMD Operating marginTXMD Operating cash flowTXMD Capital expendituresTXMD Return on equityTXMD Stock buybacksTXMD Dividends paidTXMD Total assetsTXMD Total liabilitiesTXMD Shareholders’ equityTXMD overview →